Imagine X5RL, a pharmaceutical company, develops a groundbreaking, patented treatment for a widespread chronic disease

Imagine X5RL, a pharmaceutical company, develops a groundbreaking, patented treatment for a widespread chronic disease. X5RL sets a high price on the treatment to recover its R&D costs, fund future innovations, and reap profits. However, many patients – especially in low-income regions -- cannot afford the treatment due to lack of – or insufficient - insurance coverage. As a result, a significant measure of the population is foreclosed from the lifesaving treatment.

Discuss!

Post a cohesive, substantive paragraph that incorporates the following ; (do NOT list as a "Q & A"):

· Is the public's financial issue X5RL's problem? Should it be?

· How can this company integrate CSR principles into its strategy to profit from its IP and also provide equitable access, and what ethical considerations should guide this approach?

· (HINT: Compare GSK and insulin producers in developing your thoughts).

· In your peer replies, please do not simply find a post to “agree with.” Engage in respectful debate and develop an engaged discussion.




https://boisestate.pressbooks.pub/buslaw2e/chapter/secured-transactions-and-bankruptcy/